Reversible therapy-related dysplastic hematopoiesis following Beta Interferon Therapy in Multiple Sclerosis Patients: Report of 2 Cases

BACKGROUND: Interferon beta-la and -1b have been increasingly used for the treatment of multiple sclerosis (MS). The most frequent systemic adverse effects are flu-like symptoms. Laboratory abnormalities include asymptomatic leukopenia and elevated hepatic transaminases. Myelodysplastic Syndrome (MD...

Descripción completa

Detalles Bibliográficos
Autores principales: Nabavi, Seyed Massood, Hamzehloo, Ali, Shams, Jalaledin, Morsali, Damineh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829218/
https://www.ncbi.nlm.nih.gov/pubmed/24250842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829218/
https://www.ncbi.nlm.nih.gov/pubmed/24250842

Ejemplares similares